Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Heliyon ; 9(10): e20167, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37800060

ABSTRACT

Background: We performed molecular epidemiological analyses of Clostridioides difficile isolates in a university hospital in Japan to reveal the risk of C. difficile infection. Methods: Cultured isolates from 919 stool samples from 869 patients obtained from July 2015 to August 2016 were subjected to toxin gene detection, ribotyping, multilocus sequence typing, antimicrobial susceptibility testing, and quantitative real-time polymerase chain reaction testing for C. difficile toxin gene expression. Results: Of the 919 stool samples from 869 patients, C. difficile was isolated from 153 samples (16.6%), of which 49 (32%) and 104 (68%) were from patients with and without C. difficile infection, respectively. Analyses showed genetic diversity, with ST8 and ST17 strains of healthcare-associated infections, some of which caused C. difficile infections. There was no significant difference in the transcription levels of C. difficile toxin genes between isolates from patients with and without C. difficile infection. Conclusions: Major Japanese clonal strains, ST8 and ST17, have been in the hospital environment for a long time and cause healthcare-associated C. difficile infections. The C. difficile toxin genes were transcribed in the isolates from both patients with and without C. difficile infection but were no significant relationship with the development of C. difficile infection.

2.
Diagn Microbiol Infect Dis ; 107(2): 116020, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37536259

ABSTRACT

A newly developed Clostridioides difficile-selective growth broth, which can be cultured under aerobic conditions, was found to have a sensitivity/specificity (98%/89%) comparable to conventional anaerobic culture methods. This might be a powerful tool for diagnosing Clostridioides difficile infection in resource-limited regions and health care settings in the future.


Subject(s)
Clostridioides difficile , Clostridium Infections , Humans , Clostridioides , Bacteriological Techniques/methods , Clostridium Infections/diagnosis , Sensitivity and Specificity
3.
J Infect Chemother ; 29(8): 809-811, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37094768

ABSTRACT

Fungal otitis externa is a disease encountered occasionally and is caused mostly by Aspergillus or Candida spp. We report a woman with fungal otitis externa who also had typical findings in the external auditory canal. The results of a culture showed coinfection with Candida auris and Aspergillus flavus. Identification of both species was performed by sequencing analysis of the 26S rDNA (D1/D2) and ß-tubulin regions. Additionally, the newly developed CHROMagar™ Candida Plus medium was a useful tool for the easy and rapid identification of C. auris. To the best of our knowledge, this is the first report of fungal otitis externa caused by coinfection with C. auris and A. flavus. This case showed good susceptibility to many antifungal drugs and fortunately had a good clinical course with 1% bifonazole cream, which was applied to the fungal coinfection. Notably, C. auris is a multidrug-resistant yeast-like fungus. The increase in drug-resistant fungi and co-infections caused by these pathogens can make the diagnosis and treatment more complex and difficult. To solve these problems, performing rapid and accurate identification and susceptibility testing using chromogenic medium and molecular biological analysis would be useful.


Subject(s)
Coinfection , Otitis Externa , Female , Humans , Aspergillus flavus , Candida auris , Coinfection/diagnosis , Coinfection/drug therapy , Otitis Externa/complications , Otitis Externa/drug therapy , Otitis Externa/microbiology , Candida , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Microbial Sensitivity Tests
4.
Microb Drug Resist ; 28(5): 539-544, 2022 May.
Article in English | MEDLINE | ID: mdl-35544685

ABSTRACT

We characterized plasmids carrying blaNDM-5 detected in Escherichia coli isolated from the infection site and stool sample of a Japanese patient, with no international travel history, by whole-genome sequencing (WGS). WGS was performed using MiSeq and MinlON sequencer followed by hybrid de novo assembly. blaNDM-5 was detected on IncX3 (blaNDM-5/IncX3) plasmids; pMTY18530-4_IncX3 in E. coli TUM18530 isolated from a wound above the pubis; pMTY18780-5_IncX3 and pMTY18781-1_IncX3 in E. coli TUM18780 and TUM18781, respectively, isolated from stool. These three plasmids resembled each other and pGSH8M-2-4, previously detected in E. coli isolated from a Tokyo Bay water sample. E. coli TUM18530 and TUM18780 belonged to sequence type (ST) 1011 and had only two single nucleotide polymorphisms on the core-genome, whereas TUM18781 belonged to ST2040. Three blaNDM-5/IncX3 plasmids (pMTY18530-4_IncX3, pMTY18780-5_IncX3, and pMTY18781-1_IncX3) exhibited conjugative transfer in vitro at an average frequency of 1.71 × 10-3 per donor cell. The transconjugant was resistant to only ß-lactams, including carbapenem, except aztreonam. Similarity of the blaNDM-5/IncX3 plasmids isolated from our patient compared with that isolated from the Tokyo bay water sample suggested that the plasmids may have already spread throughout the Japanese community. The blaNDM-5/IncX3 plasmid exhibited potential for easy transmission to different strains in the patient's intestine.


Subject(s)
Escherichia coli , beta-Lactamases , Anti-Bacterial Agents/pharmacology , Escherichia coli/genetics , Humans , Microbial Sensitivity Tests , Plasmids/genetics , Water , beta-Lactamases/genetics
5.
Anaerobe ; 73: 102491, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34861365

ABSTRACT

We report the first case of bacteremia caused by Veillonella atypica in a morbid elderly female patient who developed obstructive pyelonephritis. She was treated with ceftriaxone and ureteral stenting; this is the first report of V. atypica infection in humans. Species identification was performed by multiplex PCR and sequencing of rpoB. The strain was susceptible to metronidazole and clindamycin but resistant to benzylpenicillin, ampicillin, ampicillin/sulbactam, and moxifloxacin.


Subject(s)
Bacteremia , Pelvic Neoplasms , Aged , Bacteremia/diagnosis , Bacteremia/drug therapy , Female , Humans , Metronidazole , Veillonella
6.
Infect Drug Resist ; 14: 5563-5574, 2021.
Article in English | MEDLINE | ID: mdl-34984011

ABSTRACT

BACKGROUND: Excrement containing antimicrobial-resistant bacteria (ARB) is discharged from the hospital sewage through wastewater treatment plants (WWTP) into rivers, increasing the antimicrobial resistance (AMR) burden on the environment. PURPOSE: We illustrate the contamination of hospital sewage tanks with ARB harboring antimicrobial resistance genes (ARGs) using comprehensive metagenomic sequencing. During the study period, we moved to a new hospital building constructed for renovation. Therefore, we investigated the difference in bacterial flora in the sewage tanks for each building with different departments, and the change in bacterial flora over time in new sewage tanks. Furthermore, we performed a comparative genome analysis of extended spectrum ß-lactamase (ESBL)-producing organisms (EPOs) from hospital sewage and clinical samples. Residual antibiotics in the sewage tank were also measured. METHODS: Metagenomic analysis was performed on the hospital sewage samples, followed by whole genome sequencing of EPOs. RESULTS: The bacterial composition of new sewage tanks was comparable with that of old tanks within 1 month after relocation and was instantly affected by excrement. The bacterial composition of sewage tanks in the old and new buildings, containing rooms where seriously ill patients were treated, was similar. Selection on CHROMagar ESBL allowed detection of EPOs harboring bla CTX-M and carbapenemase genes in all sewage tanks. One of the sewage Escherichia coli strain comprising ST393 harboring bla CTX-M-27 corresponded to the clinical isolates based on core genome analysis. Moreover, the levels of levofloxacin and clarithromycin in the hospital sewage were 0.0325 and 0.0135 µg/mL, respectively. CONCLUSION: Hospital sewage was contaminated with many ARB species, ARGs and residual antibiotics, which can cause a burden on WWTP sewage treatment. The bacterial flora in the sewage tank was rapidly affected, especially by the ward with seriously ill patients. AMR monitoring of hospital sewage may help detect carriers prior to nosocomial ARB-associated outbreaks and control the outbreaks.

7.
Cell ; 174(3): 636-648.e18, 2018 07 26.
Article in English | MEDLINE | ID: mdl-30017246

ABSTRACT

The ex vivo generation of platelets from human-induced pluripotent cells (hiPSCs) is expected to compensate donor-dependent transfusion systems. However, manufacturing the clinically required number of platelets remains unachieved due to the low platelet release from hiPSC-derived megakaryocytes (hiPSC-MKs). Here, we report turbulence as a physical regulator in thrombopoiesis in vivo and its application to turbulence-controllable bioreactors. The identification of turbulent energy as a determinant parameter allowed scale-up to 8 L for the generation of 100 billion-order platelets from hiPSC-MKs, which satisfies clinical requirements. Turbulent flow promoted the release from megakaryocytes of IGFBP2, MIF, and Nardilysin to facilitate platelet shedding. hiPSC-platelets showed properties of bona fide human platelets, including circulation and hemostasis capacities upon transfusion in two animal models. This study provides a concept in which a coordinated physico-chemical mechanism promotes platelet biogenesis and an innovative strategy for ex vivo platelet manufacturing.


Subject(s)
Blood Platelets/metabolism , Cell Culture Techniques/methods , Thrombopoiesis/physiology , Bioreactors , Cell Culture Techniques/instrumentation , Humans , Hydrodynamics , Induced Pluripotent Stem Cells/metabolism , Megakaryocytes/metabolism , Megakaryocytes/physiology
8.
J Immunol ; 177(2): 1296-305, 2006 Jul 15.
Article in English | MEDLINE | ID: mdl-16818790

ABSTRACT

Zinc (Zn) is an essential nutrient, and its deficiency causes growth retardation, immunodeficiency, and neuronal degeneration. However, the precise roles and molecular mechanism(s) of Zn function in immune response have not been clarified. Mast cells (MCs) are granulated cells that play a pivotal role in allergic reactions and inflammation. The granules of MCs contain various chemical mediators and inflammatory cytokines that are released upon FcepsilonRI cross-linking. In this study, we report that Zn is essential for MC activation both in vitro and in vivo. We showed that a Zn chelator, N,N,N,N-tetrakis (2-pyridylmethyl) ethylenediamine, inhibited in vivo allergic reactions such as PCA and PSA. Consistent with this, N,N,N,N-tetrakis (2-pyridylmethyl) ethylenediamine significantly inhibited the FcepsilonRI-induced degranulation and cytokine production. We found that Zn was required for FcepsilonRI-induced translocation of granules to the plasma membrane, a process that we have shown to be important for MC degranulation. In addition, we showed that Zn was essential for plasma membrane translocation of protein kinase C and subsequent nuclear translocation of NF-kappaB, leading to cytokine production, such as IL-6 and TNF-alpha. These results revealed that Zn was involved in multiple steps of FcepsilonRI-induced MC activation and required for degranulation and cytokine production.


Subject(s)
Cell Degranulation/immunology , Mast Cells/immunology , Mast Cells/metabolism , Receptors, IgE/physiology , Zinc/physiology , Animals , Biological Transport/drug effects , Biological Transport/immunology , Calcium/metabolism , Cell Degranulation/drug effects , Cells, Cultured , Chelating Agents/chemistry , Cytoplasmic Granules/drug effects , Cytoplasmic Granules/metabolism , Ethylenediamines/chemistry , Mast Cells/drug effects , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Microtubules/metabolism , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Passive Cutaneous Anaphylaxis/drug effects , Passive Cutaneous Anaphylaxis/immunology , Phosphorylation , Receptors, IgE/antagonists & inhibitors , Tyrosine/metabolism , Zinc/chemistry
9.
J Cell Biol ; 170(1): 115-26, 2005 Jul 04.
Article in English | MEDLINE | ID: mdl-15998803

ABSTRACT

The aggregation of high affinity IgE receptors (Fcepsilon receptor I [FcepsilonRI]) on mast cells is potent stimulus for the release of inflammatory and allergic mediators from cytoplasmic granules. However, the molecular mechanism of degranulation has not yet been established. It is still unclear how FcepsilonRI-mediated signal transduction ultimately regulates the reorganization of the cytoskeleton and how these events lead to degranulation. Here, we show that FcepsilonRI stimulation triggers the formation of microtubules in a manner independent of calcium. Drugs affecting microtubule dynamics effectively suppressed the FcepsilonRI-mediated translocation of granules to the plasma membrane and degranulation. Furthermore, the translocation of granules to the plasma membrane occurred in a calcium-independent manner, but the release of mediators and granule-plasma membrane fusion were completely dependent on calcium. Thus, the degranulation process can be dissected into two events: the calcium-independent microtubule-dependent translocation of granules to the plasma membrane and calcium-dependent membrane fusion and exocytosis. Finally, we show that the Fyn/Gab2/RhoA (but not Lyn/SLP-76) signaling pathway plays a critical role in the calcium-independent microtubule-dependent pathway.


Subject(s)
Cell Membrane/immunology , Mast Cells/immunology , Mast Cells/metabolism , Microtubules/metabolism , Receptors, IgE/immunology , Secretory Vesicles/immunology , Adaptor Proteins, Signal Transducing , Animals , Calcium/metabolism , Calcium Signaling/drug effects , Calcium Signaling/immunology , Cell Degranulation/physiology , Cells, Cultured , Exocytosis/drug effects , Exocytosis/immunology , Inflammation Mediators/immunology , Inflammation Mediators/metabolism , Mast Cells/cytology , Membrane Fusion/drug effects , Membrane Fusion/immunology , Mice , Mice, Inbred C57BL , Phosphoproteins/metabolism , Protein Transport/drug effects , Protein Transport/immunology , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-fyn , Receptor Aggregation/immunology , Secretory Vesicles/metabolism , Signal Transduction/drug effects , Signal Transduction/immunology , rhoA GTP-Binding Protein/metabolism , src-Family Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...